Influenza and Tdap Vaccination Coverage Among Pregnant Women - United States, April 2020
- PMID: 33001873
- PMCID: PMC7537555
- DOI: 10.15585/mmwr.mm6939a2
Influenza and Tdap Vaccination Coverage Among Pregnant Women - United States, April 2020
Abstract
Vaccination of pregnant women with influenza vaccine and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) can decrease the risk for influenza and pertussis among pregnant women and their infants. The Advisory Committee on Immunization Practices (ACIP) recommends that all women who are or might be pregnant during the influenza season receive influenza vaccine, which can be administered at any time during pregnancy (1). ACIP also recommends that women receive Tdap during each pregnancy, preferably during the early part of gestational weeks 27-36 (2,3). Despite these recommendations, vaccination coverage among pregnant women has been found to be suboptimal with racial/ethnic disparities persisting (4-6). To assess influenza and Tdap vaccination coverage among women pregnant during the 2019-20 influenza season, CDC analyzed data from an Internet panel survey conducted during April 2020. Among 1,841 survey respondents who were pregnant anytime during October 2019-January 2020, 61.2% reported receiving influenza vaccine before or during their pregnancy, an increase of 7.5 percentage points compared with the rate during the 2018-19 season. Among 463 respondents who had a live birth by their survey date, 56.6% reported receiving Tdap during pregnancy, similar to the 2018-19 season (4). Vaccination coverage was highest among women who reported receiving a provider offer or referral for vaccination (influenza = 75.2%; Tdap = 72.7%). Compared with the 2018-19 season, increases in influenza vaccination coverage were observed during the 2019-20 season for non-Hispanic Black (Black) women (14.7 percentage points, to 52.7%), Hispanic women (9.9 percentage points, to 67.2%), and women of other non-Hispanic (other) races (7.9 percentage points, to 69.6%), and did not change for non-Hispanic White (White) women (60.6%). As in the 2018-19 season, Hispanic and Black women had the lowest Tdap vaccination coverage (35.8% and 38.8%, respectively), compared with White women (65.5%) and women of other races (54.0%); in addition, a decrease in Tdap vaccination coverage was observed among Hispanic women in 2019-20 compared with the previous season. Racial/ethnic disparities in influenza vaccination coverage decreased but persisted, even among women who received a provider offer or referral for vaccination. Consistent provider offers or referrals, in combination with conversations culturally and linguistically tailored for patients of all races/ethnicities, could increase vaccination coverage among pregnant women in all racial/ethnic groups and reduce disparities in coverage.
Conflict of interest statement
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
Figures
![FIGURE](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7537555/bin/mm6939a2-F.gif)
Similar articles
-
Influenza and Tdap Vaccination Coverage Among Pregnant Women - United States, April 2018.MMWR Morb Mortal Wkly Rep. 2018 Sep 28;67(38):1055-1059. doi: 10.15585/mmwr.mm6738a3. MMWR Morb Mortal Wkly Rep. 2018. PMID: 30260946 Free PMC article.
-
Variation in Tdap and Influenza Vaccination Coverage Among Pregnant Women by Insurance Type - Florida, 2016-2018.MMWR Morb Mortal Wkly Rep. 2020 Jan 24;69(3):72-76. doi: 10.15585/mmwr.mm6903a4. MMWR Morb Mortal Wkly Rep. 2020. PMID: 31971934 Free PMC article.
-
Coverage with Tetanus, Diphtheria, and Acellular Pertussis Vaccine and Influenza Vaccine Among Pregnant Women - Minnesota, March 2013-December 2014.MMWR Morb Mortal Wkly Rep. 2017 Jan 20;66(2):56-59. doi: 10.15585/mmwr.mm6602a4. MMWR Morb Mortal Wkly Rep. 2017. PMID: 28103212 Free PMC article.
-
Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2008 May 30;57(RR-4):1-51. MMWR Recomm Rep. 2008. PMID: 18509304 Review.
-
Factors associated with Tdap vaccination receipt during pregnancy: a cross-sectional study.Public Health. 2020 Feb;179:38-44. doi: 10.1016/j.puhe.2019.10.001. Epub 2019 Nov 11. Public Health. 2020. PMID: 31726399 Review.
Cited by
-
Assessing the Impact of the COVID-19 Pandemic on Pregnant Women's Attitudes towards Childhood Vaccinations: A Cross-Sectional Study.Vaccines (Basel). 2024 Apr 29;12(5):473. doi: 10.3390/vaccines12050473. Vaccines (Basel). 2024. PMID: 38793724 Free PMC article.
-
Effectiveness of cocoon strategy vaccination on prevention of influenza-like illness in young infants.Hum Vaccin Immunother. 2024 Dec 31;20(1):2350090. doi: 10.1080/21645515.2024.2350090. Epub 2024 May 13. Hum Vaccin Immunother. 2024. PMID: 38738691 Free PMC article.
-
Routine Vaccination During Pregnancy Among People Living With HIV in the United States.JAMA Netw Open. 2024 May 1;7(5):e249531. doi: 10.1001/jamanetworkopen.2024.9531. JAMA Netw Open. 2024. PMID: 38696165 Free PMC article.
-
Vaccination coverage during pregnancy and factors associated with refusal of recommended vaccinations: An Italian cross sectional study.Vaccine X. 2024 Apr 8;18:100483. doi: 10.1016/j.jvacx.2024.100483. eCollection 2024 Jun. Vaccine X. 2024. PMID: 38623567 Free PMC article.
-
Maternal Vaccination in Pregnancy: An Assessment of Influenza, Pertussis, and COVID-19 Vaccination Rates in Cracow, Poland.Med Sci Monit. 2024 Mar 12;30:e943304. doi: 10.12659/MSM.943304. Med Sci Monit. 2024. PMID: 38525559 Free PMC article.
References
-
- Havers FP, Moro PL, Hunter P, Hariri S, Bernstein H. Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the Advisory Committee on Immunization Practices—United States, 2019. MMWR Morb Mortal Wkly Rep 2020;69:77–83. 10.15585/mmwr.mm6903a5 - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous